Tricuspid Annular Plane Systolic Excursion/Systolic Pulmonary Artery Pressure Ratio and Cardiorenal Syndrome Type 2 in the Systemic Sclerosis EUSTAR Cohort
© 2023 The Authors. Arthritis Care & Research published by Wiley Periodicals LLC on behalf of American College of Rheumatology..
OBJECTIVE: The aim of the study was to evaluate the association between the tricuspid annular plane systolic excursion (TAPSE)/systolic pulmonary artery pressure (sPAP) ratio and estimated glomerular filtration rate (eGFR) and their association with mortality in the European Scleroderma Trials and Research (EUSTAR) cohort.
METHODS: Patients with systemic sclerosis (SSc) from the EUSTAR database with TAPSE, sPAP, and parameters required to calculate eGFR were included. Logistic regression and Cox regression analysis were performed to evaluate TAPSE/sPAP as a risk factor for chronic kidney disease (CKD) and overall survival.
RESULTS: A total of 2,370 patients with SSc were included; 284 (12%) patients had CKD stage 3a-5. TAPSE/sPAP (odds ratio [OR] 0.479; 95% CI 0.310-0.743; P < 0.001), arterial hypertension (OR 3.118; 95% CI 2.173-4.475; P < 0.001), diastolic dysfunction (OR 1.670; 95% CI 1.148-2.428; P < 0.01), and N-terminal pro-B-type natriuretic peptide (OR 1.165; 95% CI 1.041-1.304; P < 0.01) were associated with CKD stage 3a-5. TAPSE/sPAP ≤0.32 mm/mm Hg (hazard ratio [HR] 3.589; 95% CI 2.236-5.761; P < 0.001), eGFR <60 mL/min per 1.73 m2 (HR 2.818; 95% CI 1.777-4.468; P < 0.001), and age (HR 1.782; 95% CI 1.348-2.356; P < 0.001) were the most significant predictive factors for all-cause mortality. A total of 276 patients with SSc had pulmonary hypertension (PH) confirmed by right heart catheterization, with 69 (25%) having CKD stage 3a-5. No difference was found in eGFR between patients with PH with reduced or normal cardiac index.
CONCLUSION: Reduced TAPSE/sPAP ratio is independently associated with CKD. TAPSE/sPAP ratio ≤0.32 mm/mm Hg and eGFR <60 mL/min per 1.73 m2 are prognostic factors for all-cause mortality. In patients with SSc with PH, eGFR is independent by reduced cardiac output.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2023 |
|---|---|
| Enthalten in: |
Arthritis care & research - (2023) vom: 17. Juli |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Colalillo, Amalia [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 05.09.2023 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1002/acr.25196 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM359587844 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM359587844 | ||
| 003 | DE-627 | ||
| 005 | 20231226081210.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/acr.25196 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1198.xml |
| 035 | |a (DE-627)NLM359587844 | ||
| 035 | |a (NLM)37458105 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Colalillo, Amalia |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Tricuspid Annular Plane Systolic Excursion/Systolic Pulmonary Artery Pressure Ratio and Cardiorenal Syndrome Type 2 in the Systemic Sclerosis EUSTAR Cohort |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 05.09.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a © 2023 The Authors. Arthritis Care & Research published by Wiley Periodicals LLC on behalf of American College of Rheumatology. | ||
| 520 | |a OBJECTIVE: The aim of the study was to evaluate the association between the tricuspid annular plane systolic excursion (TAPSE)/systolic pulmonary artery pressure (sPAP) ratio and estimated glomerular filtration rate (eGFR) and their association with mortality in the European Scleroderma Trials and Research (EUSTAR) cohort | ||
| 520 | |a METHODS: Patients with systemic sclerosis (SSc) from the EUSTAR database with TAPSE, sPAP, and parameters required to calculate eGFR were included. Logistic regression and Cox regression analysis were performed to evaluate TAPSE/sPAP as a risk factor for chronic kidney disease (CKD) and overall survival | ||
| 520 | |a RESULTS: A total of 2,370 patients with SSc were included; 284 (12%) patients had CKD stage 3a-5. TAPSE/sPAP (odds ratio [OR] 0.479; 95% CI 0.310-0.743; P < 0.001), arterial hypertension (OR 3.118; 95% CI 2.173-4.475; P < 0.001), diastolic dysfunction (OR 1.670; 95% CI 1.148-2.428; P < 0.01), and N-terminal pro-B-type natriuretic peptide (OR 1.165; 95% CI 1.041-1.304; P < 0.01) were associated with CKD stage 3a-5. TAPSE/sPAP ≤0.32 mm/mm Hg (hazard ratio [HR] 3.589; 95% CI 2.236-5.761; P < 0.001), eGFR <60 mL/min per 1.73 m2 (HR 2.818; 95% CI 1.777-4.468; P < 0.001), and age (HR 1.782; 95% CI 1.348-2.356; P < 0.001) were the most significant predictive factors for all-cause mortality. A total of 276 patients with SSc had pulmonary hypertension (PH) confirmed by right heart catheterization, with 69 (25%) having CKD stage 3a-5. No difference was found in eGFR between patients with PH with reduced or normal cardiac index | ||
| 520 | |a CONCLUSION: Reduced TAPSE/sPAP ratio is independently associated with CKD. TAPSE/sPAP ratio ≤0.32 mm/mm Hg and eGFR <60 mL/min per 1.73 m2 are prognostic factors for all-cause mortality. In patients with SSc with PH, eGFR is independent by reduced cardiac output | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Pellicano, Chiara |e verfasserin |4 aut | |
| 700 | 1 | |a Ananyeva, Lidia P |e verfasserin |4 aut | |
| 700 | 1 | |a Hachulla, Eric |e verfasserin |4 aut | |
| 700 | 1 | |a Cuomo, Giovanna |e verfasserin |4 aut | |
| 700 | 1 | |a Györfi, Andrea-Hermina |e verfasserin |4 aut | |
| 700 | 1 | |a Czirják, László |e verfasserin |4 aut | |
| 700 | 1 | |a de Vries-Bouwstra, Jeska |e verfasserin |4 aut | |
| 700 | 1 | |a Mouthon, Luc |e verfasserin |4 aut | |
| 700 | 1 | |a Poormoghim, Hadi |e verfasserin |4 aut | |
| 700 | 1 | |a Del Galdo, Francesco |e verfasserin |4 aut | |
| 700 | 1 | |a Hunzelmann, Nicolas |e verfasserin |4 aut | |
| 700 | 1 | |a Spierings, Julia |e verfasserin |4 aut | |
| 700 | 1 | |a Kuwana, Masataka |e verfasserin |4 aut | |
| 700 | 1 | |a Rosato, Edoardo |e verfasserin |4 aut | |
| 700 | 0 | |a and the EUSTAR Collaborators |e verfasserin |4 aut | |
| 700 | 1 | |a Gigante, Antonietta |e investigator |4 oth | |
| 700 | 1 | |a Alunni Fegatelli, Danilo |e investigator |4 oth | |
| 700 | 1 | |a Garzanova, Ludmila |e investigator |4 oth | |
| 700 | 1 | |a Launay, David |e investigator |4 oth | |
| 700 | 1 | |a Di Vico, Claudio |e investigator |4 oth | |
| 700 | 1 | |a Bergmann, Christina |e investigator |4 oth | |
| 700 | 1 | |a Varju, Cecilia |e investigator |4 oth | |
| 700 | 1 | |a Scherer, H U |e investigator |4 oth | |
| 700 | 1 | |a Chaigne, Benjamin |e investigator |4 oth | |
| 700 | 1 | |a Andalib, Elham |e investigator |4 oth | |
| 700 | 1 | |a Alcacer-Pitarch, Begonya |e investigator |4 oth | |
| 700 | 1 | |a Moinzadeh, Pia |e investigator |4 oth | |
| 700 | 1 | |a Van Laar, Jacob |e investigator |4 oth | |
| 700 | 1 | |a Watanabe, Shinji |e investigator |4 oth | |
| 700 | 1 | |a Distler, Oliver |e investigator |4 oth | |
| 700 | 1 | |a Jordan, Suzana |e investigator |4 oth | |
| 700 | 1 | |a Riemekasten, Gabriela |e investigator |4 oth | |
| 700 | 1 | |a Marschner, Gabriele |e investigator |4 oth | |
| 700 | 1 | |a Carreira, Patricia E |e investigator |4 oth | |
| 700 | 1 | |a Martin, Maria |e investigator |4 oth | |
| 700 | 1 | |a Siegert, Elise |e investigator |4 oth | |
| 700 | 1 | |a Kedor, Claudia |e investigator |4 oth | |
| 700 | 1 | |a Simeón-Aznar, Carmen-Pilar |e investigator |4 oth | |
| 700 | 1 | |a Del Castillo, Alfredo Guillén |e investigator |4 oth | |
| 700 | 1 | |a Marcoccia, Antonella |e investigator |4 oth | |
| 700 | 1 | |a Gabrielli, Armando |e investigator |4 oth | |
| 700 | 1 | |a Martin, Mickaël |e investigator |4 oth | |
| 700 | 1 | |a Landron, Cédric |e investigator |4 oth | |
| 700 | 1 | |a Smith, Vanessa |e investigator |4 oth | |
| 700 | 1 | |a Airò, Paolo |e investigator |4 oth | |
| 700 | 1 | |a Lazzaroni, Maria-Grazia |e investigator |4 oth | |
| 700 | 1 | |a Villiger, Peter |e investigator |4 oth | |
| 700 | 1 | |a Adler, Sabine |e investigator |4 oth | |
| 700 | 1 | |a Iannone, Florenzo |e investigator |4 oth | |
| 700 | 1 | |a Idolazzi, Luca |e investigator |4 oth | |
| 700 | 1 | |a Müller-Ladner, Ulf |e investigator |4 oth | |
| 700 | 1 | |a Alegre-Sancho, Juan Jose |e investigator |4 oth | |
| 700 | 1 | |a Truchetet, Marie-Elise |e investigator |4 oth | |
| 700 | 1 | |a Dagna, Lorenzo |e investigator |4 oth | |
| 700 | 1 | |a Matucci Cerinic, Marco |e investigator |4 oth | |
| 700 | 1 | |a Gheorghiu, Ana Maria |e investigator |4 oth | |
| 700 | 1 | |a Ramazan, Ana-Maria |e investigator |4 oth | |
| 700 | 1 | |a Cauli, Alberto |e investigator |4 oth | |
| 700 | 1 | |a Castellví, Ivan |e investigator |4 oth | |
| 700 | 1 | |a Iudici, Michele |e investigator |4 oth | |
| 700 | 1 | |a Solanki, Kamal |e investigator |4 oth | |
| 700 | 1 | |a Soukup, Tomas |e investigator |4 oth | |
| 700 | 1 | |a Allanore, Yannick |e investigator |4 oth | |
| 700 | 1 | |a Limonta, Massimiliano |e investigator |4 oth | |
| 700 | 1 | |a Pârvu, Magda |e investigator |4 oth | |
| 700 | 1 | |a Moroncini, Gianluca |e investigator |4 oth | |
| 700 | 1 | |a Zanatta, Elisabetta |e investigator |4 oth | |
| 700 | 1 | |a Selvi, Enrico |e investigator |4 oth | |
| 700 | 1 | |a Tanaka, Yoshiya |e investigator |4 oth | |
| 700 | 1 | |a Selmi, Carlo Francesco |e investigator |4 oth | |
| 700 | 1 | |a Bielecka, Otylia Kowal |e investigator |4 oth | |
| 700 | 1 | |a Cutolo, Maurizio |e investigator |4 oth | |
| 700 | 1 | |a Rednic, Simona |e investigator |4 oth | |
| 700 | 1 | |a Henes, Jörg |e investigator |4 oth | |
| 700 | 1 | |a Kahl, Sarah |e investigator |4 oth | |
| 700 | 1 | |a Del Papa, Nicoletta |e investigator |4 oth | |
| 700 | 1 | |a Denton, Christopher |e investigator |4 oth | |
| 700 | 1 | |a Schmeiser, Tim |e investigator |4 oth | |
| 700 | 1 | |a Brzosko, Marek |e investigator |4 oth | |
| 700 | 1 | |a Sfikakis, Petros |e investigator |4 oth | |
| 700 | 1 | |a Walker, Ulrich |e investigator |4 oth | |
| 700 | 1 | |a Negrini, Simone |e investigator |4 oth | |
| 700 | 1 | |a Riccieri, Valeria |e investigator |4 oth | |
| 700 | 1 | |a Fathi, Nihal |e investigator |4 oth | |
| 700 | 1 | |a Radic, Mislav |e investigator |4 oth | |
| 700 | 1 | |a Heitmann, Stefan |e investigator |4 oth | |
| 700 | 1 | |a Cantatore, Francesco Paolo |e investigator |4 oth | |
| 700 | 1 | |a de Souza Müller, Carolina |e investigator |4 oth | |
| 700 | 1 | |a Foti, Rosario |e investigator |4 oth | |
| 700 | 1 | |a Couto, Maura |e investigator |4 oth | |
| 700 | 1 | |a Rezus, Elena |e investigator |4 oth | |
| 700 | 1 | |a Balbir-Gurman, Alexandra |e investigator |4 oth | |
| 700 | 1 | |a Krasowska, Dorota |e investigator |4 oth | |
| 700 | 1 | |a Opris-Belinski, Daniela |e investigator |4 oth | |
| 700 | 1 | |a Aringer, Martin |e investigator |4 oth | |
| 700 | 1 | |a Anic, Branimir |e investigator |4 oth | |
| 700 | 1 | |a Baresic, Marko |e investigator |4 oth | |
| 700 | 1 | |a Mayer, Miroslav |e investigator |4 oth | |
| 700 | 1 | |a Yavuz, Sule |e investigator |4 oth | |
| 700 | 1 | |a Agachi, Svetlana |e investigator |4 oth | |
| 700 | 1 | |a Oksel, Fahrettin |e investigator |4 oth | |
| 700 | 1 | |a Zdrojewski, Zbigniew |e investigator |4 oth | |
| 700 | 1 | |a Rodriguez-Pinto, Ignasi |e investigator |4 oth | |
| 700 | 1 | |a Geroldinger-Simic, Marija |e investigator |4 oth | |
| 700 | 1 | |a Lledó-Ibañez, Gema Maria |e investigator |4 oth | |
| 700 | 1 | |a Kubacki, Torsten |e investigator |4 oth | |
| 700 | 1 | |a Batalov, Anastas |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Arthritis care & research |d 2010 |g (2023) vom: 17. Juli |w (DE-627)NLM195433068 |x 2151-4658 |7 nnns |
| 773 | 1 | 8 | |g year:2023 |g day:17 |g month:07 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/acr.25196 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 17 |c 07 | ||